[bionet.sci-resources] Supplement to NIH Guide, vol. 19, no. 19

kristoff@GENBANK.BIO.NET (Dave Kristofferson) (05/26/90)

These were mailed separately from the NIH today as an addition to the
18 May 1990 issue of the Guide.

D.K.

----------------------------------------------------------------------

GUIDELINES

MINORITY INSTITUTIONAL RESEARCH TRAINING PROGRAM

PA:  PA-90-13

P.T. 42, FF; K.W. 0720005, 0715040, 0715165, 0785070

National Heart, Lung, and Blood Institute

Application Receipt Date:  August 22, 1990

I. OBJECTIVES OF THE PROGRAM

The Minority Institutional Research Training Program is
intended to:

1.  Train graduate students, health professional students
who will take a minimum of one year from his/her
professional training, and postdoctoral students in minority
schools that have the potential to develop a meritorious
program in cardiovascular, pulmonary or hematologic
research* for research careers in areas relevant to these
diseases.

2.  Stimulate cardiovascular, pulmonary and hematologic
diseases and hematologic resources research, prevention,
control and education by offering minority school graduate
students, health professional students, and postdoctoral
students the opportunity to enhance their research
capabilities in these areas.

II.  BACKGROUND

Many studies have emphasized the need for minority
individuals to participate in modern research activities to
develop their investigative talents.
Programs exit at the National Institutes of Health that are
designed to answer this need, such as the Minority
Biomedical Research Support Program, the Minority Access to
Research Careers Program, and the Minority Hypertension
Research Development Summer Program.  Even though these
programs are successful in meeting their specific objectives
and career development goals, graduate students, health
professional students, and postdoctoral students in minority
schools need further opportunities to develop biomedical and
behavioral research skills.

The Minority Institutional Research Training Program is
designed to offer research training grant awards in
cardiovascular, pulmonary and hematologic research to
minority schools to enable qualified graduate students,
health professional students, and postdoctoral students to
participate in research programs.  It is expected to attract
students in their developmental stages, increase their
awareness of these diseases, and to acquaint them with
career opportunities in research.

III.  ELIGIBILITY

A. Minority School

The Institution must be a medical or non-medical college,
university or equivalent school in which students of
underrepresented minority groups, including Blacks, Hispanics
American Indians, and Asian or Pacific Islanders, comprise a
majority or a significant proportion of the school
enrollment.
It must have the ongoing staff and facilities required for the
proposed program.  The program director at the minority
school will be responsible for the selection and appointment
of trainees and the overall direction of the training
program.

B. Trainees

The individual to be trained must (1) be a citizen of the
United States, a non-citizen national, or have been admitted
to the United States for permanent residence at the time of
appointment for training; (2) have a baccalaureate degree
and must be training at the post-baccalaureate level in a
relevant biomedical or behavioral science and have made a
strong commitment to completing a doctoral degree; (3) be
enrolled in a minority health professional school; or (4)
have a doctoral degree or equivalent in a biomedical or
behavioral science.

C. Research Center

The minority institution must identify and collaborate with
a research center (medical school or comparable institution)
that has strong, well-established cardiovascular, pulmonary
or hematologic research and research training programs.
Cooperation between institutions is needed to provide each
trainee with a mentor who is recognized as an accomplished
investigator in cardiovascular, pulmonary or hematologic
research and who will assist the advisor at the minority
institution in the trainee's development and research plan.
Plans for summer training as well as academic year training
should be developed by the student and advisor at the
trainee's home institution in collaboration with the mentor
at the research center.  It is expected that both advisor
and mentor will guide the trainee through the initial
training period and continue this interaction throughout the
award.

IV.  IMPLEMENTATION

Minority institutions will compete for research training
grants of up to five years' duration.  Funds will be
provided on an annual basis to develop and maintain a stable
research training experience for qualified students.  Awards
recommended for the continuation years will be made
contingent upon satisfactory progress during the preceding
year, upon the availability of funds, and the requisite
level authorization for continued support of training
activities.  Successful applicants may compete for a second
award of up to five years' duration upon completion of the
initial grant period.

The minority institution will identify and complete
arrangements with an established cardiovascular, pulmonary
or hematologic research center(s) before submitting an
application.  Graduate trainees appointed to the grant may
receive support for up to five years.  Postdoctoral trainees
appointed to the grant may receive support for up to three
years.  He/she will have a faculty advisor at the minority
institution and they will jointly select a faculty mentor at
the research center.  A written commitment to the training
plan by potential faculty mentors at the research center,
the department(s) involved and countersigned by an
institutional official, must be part of the application.
The students may spend not more than 50 percent time at the
research training center over the course of the year
including a period of intensive research training during the
summer.  Students will be expected to meet the degree
requirements at their institution.

V. PROVISIONS OF THE AWARD

The trainees may be appointed for 9 - 12 months at any time
during the course of the budget period after he/she has been
accepted as a full-time student.  A strong interest in a
cardiovascular, pulmonary or hematologic research career
must be evident.

Funds may be requested for:

A. Stipends - Current stipend level for graduate and health
professional student trainees at all levels of experience is
$708 per month.  Current stipend levels for postdoctoral
trainees range from $1,417 - $2,625 per month.

B. Tuition, Fees, when necessary, and Medical Insurance
(individual coverage), when regularly charged to all
students regardless of their source of support, are
allowable trainee costs.  In addition, tuition and fees
charged by the research center during the summer or off-
quarter period are allowable.

C. Trainee Travel Costs - The institution may request funds
to cover the costs of trainee travel including attendance at
scientific meetings which are necessary to the individual's
training.  Funds for commuting expenses that are clearly in
excess of those incurred during the usual home to work
travel of the trainee may also be requested.

D. Training Related Expenses - Funds are provided to
partially defray the cost of training such as staff
salaries, equipment, research supplies, staff travel and
other expenses.  The current level of training related
expenses is $1,500 per annum per full-time graduate student
trainees or health professional student trainees, and $2,500
per annum for postdoctoral trainees.

E. Indirect Costs - The Notice of Grant Award will provide
indirect costs based on 8 percent of total direct costs
(exclusive of tuition and fees, and expenditures for
equipment whichever is less).

Payback Agreement - A National Research Service Award
Payback Agreement must be signed by each individual who is
to receive a stipend through an institutional award.  This
form and the statement of appointment are submitted annually
at the time of each appointment.  These forms will be
completed beginning with the initial period of support even
though the first 12 months is excluded from the cumulative
payback requirement.

VI.  REVIEW PROCEDURES

All applications responding to this announcement will be
reviewed for scientific and technical merit by the Research
Manpower Review Committee of the Division of Extramural
Affairs, NHLBI, followed by a second level review by the
National Heart, Lung, and Blood Advisory Council.

Review Criteria

The factors to be considered in the evaluation of the
proposed training program are:

o Adequacy of faculty, facilities, and resources for the
proposed research training, both at the minority institution
and the research center;

o Adequacy of the cooperative arrangements between the
minority institution and the research program;

o Commitment of the relevant faculty and the two
institutions to the goals of the training program;

o Procedures for evaluation of the impact of the program on
the trainees involved.

VII.  APPLICATION PROCEDURE

Submit applications on an Institutional National Research
Service Award application Form PHS-398 (Rev.  10/88).  This
form is available at the applicant institution's office of
sponsored research or may be obtained
from the three program offices of the National Heart, Lung,
and Blood Institute, listed below.  When submitting the
application, identify the Minority Institutional Research
Training Program PA-90-13 on line 2 of the application face
page.  Special instructions for preparing the application
are included in these guidelines.

Applications

Send the completed application and four (4) signed exact
photocopies by the announced receipt date to:

Division of Research Grants
National Institutes of Health
Westwood Building, Room 240
Bethesda, MD  20892**

Two
additional copies of the application should be sent to the
Executive Secretary of the Research Manpower Review
Committee listed above.

Program Information

Information regarding this program may be obtained from one
of the following:

John Fakunding, Ph.D.
Chief, Research Training and Development Branch
Division of Heart and Vascular Diseases
National Heart, Lung, and Blood Institute
Federal Building, Room 3C04
Bethesda, MD  20892
Telephone:  (301) 496-1724

Diane Aiken
Division of Lung Diseases
National Heart, Lung, and Blood institute
Federal Building, Room 640A
Bethesda, MD  20892
Telephone:  (301) 496-7668

Helena Mishoe, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
Federal Building, Room 504D
Bethesda, MD  20892
Telephone:  (301) 496-6931

*  Within NHLBI, the term "hematologic diseases" covers research
into many aspects of bone marrow function and disorders of the
red cell, megakaryocyte, platelet, and coagulation system.  Other
Institutes of the NIH are responsible for research on disorders
of white cells, including the leukemias and other blood
malignancies, and basic immunology related to the lymphoid
system.  Therefore NHLBI cannot provide support for such studies.




GUIDELINES

MINORITY SCHOOL FACULTY DEVELOPMENT AWARD

PA:  PA-90-14

P.T. 34, FF; K.W. 0720005, 0715040, 0715165, 0785070

NATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Application Receipt Date:  August 22, 1990

I.   OBJECTIVES OF THE PROGRAM

The Minority School Faculty Development Award is intended to:

1.   Encourage the development of faculty investigators at
minority schools in areas relevant to cardiovascular, pulmonary
and hematologic diseases*.

2.   Stimulate cardiovascular, pulmonary and hematologic disease
research, prevention, control and education by offering minority
school faculty members the opportunity to enhance their research
capabilities in these areas.

II.  BACKGROUND

The proportion of biomedical investigators who are members of
minority groups is strikingly lower than the percentage of
minority U.S. citizens.  While 12 percent of the population is
Black, less than 0.25 percent of persons holding a Ph.D. in
science are Black.  The figures are even lower for Black Ph.Ds.
in the biomedical sciences.  Furthermore, the number of
doctorates, both M.Ds. and Ph.Ds., in other ethnic minority
groups (such as Native Americans or Hispanics) is proportionally
lower than for Blacks.  Vigorous recruitment is underway
throughout the government, academic institutions, hospitals,
research institutions and industry.

One method of addressing this problem is by increasing
capabilities of faculty members at minority schools.  In so
doing, the pool of biomedical and behavioral investigators in
cardiovascular, pulmonary and hematologic research will be
increased.  Furthermore, their graduate and undergraduate
students, most of whom will be minority individuals, will become
more cognizant of research opportunities in cardiovascular,
pulmonary and hematologic disease areas.

This program is designed to offer research support in
cardiovascular, pulmonary and hematologic diseases to minority
school faculty members who have the interest and capabilities of
doing modern, sophisticated research in these areas.

Despite a recent decline in the death rate from coronary heart
disease, cardiovascular disease continues to be the number one
cause of death in the United States.  Arteriosclerosis and
hypertension account for almost one million deaths annually.  An
estimated 40 million Americans have diseases of the heart and
blood vessels, resulting in a large burden of acute and chronic
illness and disability.  Heart and blood vessel diseases cost the
economy more then $50 billion per year in wages, lost
productivity and expenses for medical care.  A wide range of
opportunities for research into the causes, diagnosis, treatment
and prevention of heart and vascular diseases have been
enumerated in the Tenth Report of the Director, National Heart,
Lung, and Blood Institute, Volume 2, Heart and Vascular Diseases
(NIH publication No. 84-2357).

Diseases of the lung constitute a major national health problem.
About one in every five persons has some chronic respiratory
problem resulting in an annual estimated cost to the nation of
over $29 billion.  In the newborn, the most common cause of death
is neonatal respiratory distress syndrome (RDS).  Neonatal RDS may be
implicated in development of adult respiratory diseases as well.
Of the adult respiratory diseases, emphysema and chronic
bronchitis are the major causes of death.  Fibrotic and
immunologic lung diseases are major causes of lung problems in
the young adult and may contribute to the development of chronic
obstructive pulmonary diseases.  Asthma, emphysema and chronic
bronchitis represent particularly pressing health problems,
affecting an estimated 17 million Americans.  Moreover, the death
rate and prevalence of these conditions have increased at an
alarming rate over the past 15 years.  As a disabling disease,
emphysema is a leading cause of worker retirement on Social
Security disability payments.

Disorders of the blood, including congenital or acquired
disorders or deficiencies, are critical contributors to health
problems of mankind.  As a consequence, they are major causes of
death and disability in the United States.  Disorders of the
blood affect not only the blood itself, but the tissues and
organs through which it flows.  Recent research findings have
revealed the widespread involvement of thrombosis in the
pathology of numerous disorders, including the development of
atherosclerosis and coronary thrombosis.  Aggressive therapy for
cancer has resulted in the increased susceptibility of patients
to bleeding disorders and has increased the demand for blood
products for therapeutic purposes.  A significant segment of the
population has inherited disorders, such as sickle cell disease,
hemophilia, or Cooley's anemia, which require life-long
hematologic attention and support.

Other diseases may be acquired or represent temporary demands,
such as replacement therapy as a result of surgical or accidental
trauma.  Research opportunities in blood resources and
transfusion medicine range from basic to clinical.  They cover
such diverse topics as the development of new blood products,
methods to improve and assure the stability and safety of these
products, and ways to improve the benefits and safety of
transfusion.

III. ELIGIBILITY

A.   Minority School

A minority school is defined as a medical or non-medical college,
university or equivalent school where (1) students of minority
ethnic groups including Blacks, Hispanics, American Indians and
Asian or Pacific Islanders comprise a majority or significant
proportion of the school enrollment and that has a commitment to
the special encouragement of minority faculty, students and
investigators and (2) few or no members of its faculty are
actively engaged in biomedical research.  The commitment of the
institution to the faculty candidate's research and development
must clearly be presented in the application including
statement(s) from the sponsor and the department chairman.

B.  Faculty Development Award Candidate

Candidates for this award are minority school faculty members who
(1) are citizens of the United States, non-citizen nationals or
permanent residents at the time of application; (2) have a
doctoral degree or equivalent in a biomedical or behavioral
science; (3) wish to receive specialized training in
cardiovascular, pulmonary, or hematologic research; and (4) have
the background and potential to benefit from the training.

Applicants may not apply for, or accept, other Public Health
Service research grant support or its equivalent at the time of
Minority School Faculty Development Award application, nor may
they apply currently for any other type of academic award.
However, they may apply for, and accept research grant support
subsequent to award of the Minority School Faculty Development
Award.

C.  Mentor at Research Center

Each candidate must also identify and complete arrangements with
a nearby mentor (within approximately 100 miles) who is
recognized as an accomplished investigator in the research area
proposed and who will provide guidance for the awardee's
development and research plan.  Plans for the intensive training
during the summer period (2 - 3 months), as well as during the
academic years, should be developed with the mentor.

The commitment of the mentor and his/her institution to both the
summer and academic year training period must be demonstrated in the
application.  A commitment from the mentor's department chairman
must be included in the application.

IV. IMPLEMENTATION

The awards will be made to the minority institution in behalf of
the awardee.  Each award will have a duration of five years and
is non-renewable.  These awards may not be transferred to another
institution.  Funding beyond the first year of the grant is
contingent upon satisfactory progress during the preceding year.

The status of the minority school faculty development award
program will be reviewed periodically from the date of the first
award to determine whether the program should be continued.  In
addition, to assess the effectiveness of the program in
fulfilling its objectives, the Institute intends to follow the
progress of the recipient for a period of five years after
completion of each grant to determine:  (1) the investigator's
professional affiliation(s), (2) his/her record of subsequent
grant or contract support, (3) his/her record of scientific
publications, and (4) the institution's research programs.

V.  PROVISIONS OF THE AWARD

A. Salary

The awardee will receive salary support up to a maximum of
$40,000 plus fringe benefits per year for five years.  All funds
must be used to support the original awardee.  Support will be
based upon the candidate's actual salary and must be consistent
with the established salary structure of the minority institution
for persons of equivalent qualifications, experience and rank.
The actual amount will be determined by the proportion of effort
devoted to this program.  Awardees must commit 100 percent of
effort during summer and/or off-quarter periods and at least 25
percent of effort during the academic year.

Support for up to 10 percent of the mentor's salary during the
summer experience may also be requested.  Details of how or if
this will be needed must be agreed upon by the mentor's
institution and included in the application.

B.  Research Support

Up to $20,000 per year will be provided for research support.
Details regarding the apportionment of these funds between the
minority institution and the research center must be worked out
with the mentor at the research center and agreed to by
representatives of both institutions.  A statement of agreement
must be provided in the application.

These research support funds may be used for:

Equipment:  Specialized research equipment essential to the
proposed program; in accordance with PHS policy, title to such
equipment will vest with the grantee institution.

Supplies:  Consumable supplies essential to the proposed program;

Travel:  domestic travel for the awardee that is essential to the
proposed program;

Tuition and fees:  if essential to the awardee's individual
research development program; and

Other:  personnel, publication costs, computer costs, or other
costs necessary for the research program.

Indirect costs will be provided for at a rate of 8 percent of the
total direct costs of each award, exclusive of tuition, fees, and
expenditures for equipment.

VI. REVIEW PROCEDURES

All applications will be reviewed for scientific and technical
merit by the Research Manpower Review Committee of the Division
of Extramural Affairs, NHLBI, followed by a second level review
by the National Heart, Lung, and Blood Advisory Council.

Review Criteria

The factors to be considered in the evaluation of the proposed
training program are:

o  the overall merit of the candidate's five-year plan for
research and the development of research skills.

o  the background and potential of the proposed candidate for
development into an independent biomedical investigator.

o  the candidate's commitment to a research career.

o  The ability of both the minority institution and the training
center to provide facilities, resources and opportunities
necessary for the candidate's research development.

o  the qualifications, ability and plans of the sponsor who will
provide the candidate with the guidance necessary for career
development in research.

VII. APPLICATION PROCEDURE

Submit applications on the regular research grant application
Form PHS 398 (Rev. 10/88).  This form is available at the
applicant institution's office of sponsored research or
may be obtained from the three program offices
of the National Heart, Lung, and Blood Institute, listed below.
When submitting the application, identify the NHLBI Minority
School Faculty Development Award PA-90-14 on line 2 of the
application face page.  Special
instructions for preparing the application are included in these
guidelines.

Applications

Send the completed application and four (4) signed exact
photocopies by the announced receipt date to:

Division of Research Grants
National Institutes of Health
Westwood Building, Room 240
Bethesda, MD  20892**

Two additional copies of the application
should be sent to the Executive Secretary of the Research
Manpower Review Committee listed above.

Program Information

Information regarding this program may be obtained from one of
the following:

John Fakunding, Ph.D.
Chief, Research Training and Development Branch
Division of Heart and Vascular Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
Federal Building, Room 3C04
Bethesda, Maryland  20892
Telephone:  (301) 496-1724

Joan Wolle, Ph.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
Westwood Building, Room 640
Bethesda, Maryland  20892
Telephone:  (301) 496-7668

Helena Mishoe, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
National Institutes of Health
Federal Building, Room 504D
Bethesda, Maryland  20892
Telephone:  (301) 496-6931

*  Within NHLBI, the term "hematologic diseases" covers research
into many aspects of bone marrow function and disorders of the
red cell, megakaryocyte, platelet and coagulation system.  Other
Institutes of the NIH are responsible for research on disorders
of white cells, including the leukemias and other blood
malignancies, and basic immunology related to the lymphoid
system.  Therefore NHLBI cannot provide support for such studies.